Kales, Helen C.

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet

Dementia and Cognitive Impairment ResearchAging, Health, and Disability

Cited by 10,430

Dementia prevention, intervention, and care

Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 6,072

Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission

Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet

Dementia and Cognitive Impairment ResearchHearing Loss and Rehabilitation

Cited by 3,860

Assessment and management of behavioral and psychological symptoms of dementia

Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ

Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes

Cited by 1,247

Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia: Number Needed to Harm

Maust, D. T., Kim, H. M., Seyfried, L. S., Chiang, C., Kavanagh, J., Schneider, L. S., & Kales, H. C. (2015) · JAMA Psychiatry

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 617

Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel

Kales, H. C., Gitlin, L. N., Lyketsos, C. G., & Dementia, T. D. E. P. O. T. A. A. M. O. T. N. S. O. (2014) · Journal of the American Geriatrics Society

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 575

Nonpharmacologic Management of Behavioral Symptoms in Dementia

Gitlin, L. N., Kales, H. C., & Lyketsos, C. G. (2012) · JAMA

Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes

Cited by 495

Risk of Mortality Among Individual Antipsychotics in Patients With Dementia

Kales, H. C., Kim, H. M., Zivin, K., Valenstein, M., Seyfried, L. S., Chiang, C., Cunningham, F., Schneider, L. S., & Blow, F. C. (2012) · American Journal of Psychiatry

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 384

Mortality Risk in Patients With Dementia Treated With Antipsychotics Versus Other Psychiatric Medications

Kales, H. C., Valenstein, M., Kim, H. M., McCarthy, J. F., Ganoczy, D., Cunningham, F., & Blow, F. C. (2007) · American Journal of Psychiatry

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 258

Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus

Kales, H. C., Lyketsos, C. G., Miller, E. M., & Ballard, C. (2019) · International Psychogeriatrics

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 220

Psychosis in Alzheimer disease—mechanisms, genetics and therapeutic opportunities

Ismail, Z., Creese, B., Aarsland, D., Kales, H. C., Lyketsos, C. G., Sweet, R. A., & Ballard, C. (2022) · Nature Reviews Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 189

Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence

Kolanowski, A., Boltz, M., Galik, E., Gitlin, L. N., Kales, H. C., Resnick, B., Van Haitsma, K. S., Knehans, A., Sutterlin, J. E., Sefcik, J. S., et al. (2017) · Nursing Outlook

Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes

Cited by 165

Evaluation of the FDA Warning Against Prescribing Citalopram at Doses Exceeding 40 mg

Zivin, K., Pfeiffer, P. N., Bohnert, A. S. B., Ganoczy, D., Blow, F. C., Nallamothu, B. K., & Kales, H. C. (2013) · American Journal of Psychiatry

Cardiac Health and Mental HealthTreatment of Major Depression

Cited by 127

Mindfulness-Based Cognitive Therapy With Older Adults: An Exploratory Study

Foulk, M. A., Ingersoll-Dayton, B., Kavanagh, J., Robinson, E., & Kales, H. C. (2014) · Journal of Gerontological Social Work

Mindfulness and Compassion InterventionsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 115

Adherence to Depression Treatment in Older Adults: A Narrative Review

Zivin, K., & Kales, H. C. (2008) · Drugs & Aging

Medication Adherence and ComplianceMental Health Treatment and Access

Cited by 110

Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression

Kales, H. C., Chen, P., Blow, F. C., Welsh, D. E., & Mellow, A. M. (2005) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes

Cited by 95

National trends in antidepressant, benzodiazepine, and other sedative-hypnotic treatment of older adults in psychiatric and primary care

Maust, D. T., Blow, F. C., Wiechers, I. R., Kales, H. C., & Marcus, S. C. (2017) · The Journal of Clinical Psychiatry

Pharmaceutical Practices and Patient OutcomesMental Health Treatment and Access

Cited by 93

Adherence to Depression Treatment in Primary Care: A Randomized Clinical Trial

Sirey, J. A., Banerjee, S., Marino, P., Bruce, M. L., Halkett, A., Turnwald, M., Chiang, C., Liles, B., Artis, A., Blow, F., et al. (2017) · JAMA Psychiatry

Medication Adherence and ComplianceMental Health Treatment and Access

Cited by 87

No end in sight: benzodiazepine use in older adults in the United States.

Maust, D. T., Kales, H. C., Wiechers, I. R., Blow, F. C., & Olfson, M. (2016) · Journal of the American Geriatrics Society

Pharmaceutical Practices and Patient OutcomesOpioid Use Disorder Treatment

Cited by 82

Opioids and other central nervous system-active polypharmacy in older adults in the United States.

Gerlach, L. B., Olfson, M., Kales, H. C., & Maust, D. T. (2017) · Journal of the American Geriatrics Society

Pharmaceutical Practices and Patient OutcomesOpioid Use Disorder Treatment

Cited by 80

When less is more, but still not enough: why focusing on limiting antipsychotics in people with dementia is the wrong policy imperative

Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2019) · Journal of the American Medical Directors Association

Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes

Cited by 76

Distress associated with dementia-related psychosis and agitation in relation to healthcare utilization and costs

Maust, D. T., Kales, H. C., McCammon, R. J., Blow, F. C., Leggett, A., & Langa, K. M. (2017) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchPalliative Care and End-of-Life Issues

Cited by 74

New-Onset Bipolar Disorder in Later Life

Sajatovic, M., Blow, F. C., Ignacio, R. V., & Kales, H. C. (2005) · The American Journal of Geriatric Psychiatry

Bipolar Disorder and TreatmentPersonality Disorders and Psychopathology

Cited by 56

Race, Gender, and Psychiatrists' Diagnosis and Treatment of Major Depression Among Elderly Patients

Kales, H. C., Neighbors, H. W., Blow, F. C., Taylor, K. K. K., Gillon, L., Welsh, D. E., Maixner, S. M., & Mellow, A. M. (2005) · Psychiatric Services

Mental Health Treatment and AccessCultural Competency in Health Care

Cited by 46